Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Receives Two US Patents for Biochips

NEW YORK, Sept. 12 (GenomeWeb News) - Zyomyx announced yesterday that the US Patent Office had recently issued the company two biochip patents.


The first, US Patent No. 6,582,969, was issued on June 24 of this year, and the second, US Patent No. 6,596,545 was issued on July 22. Both cover multiplexed, in vitro screening of biomolecular activity for drug development, clinical diagnostics, and proteomic and genomic research using miniaturized, micro-fabricated chips.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.